Live Chat
Today's Hours: 8:00am - 8:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    Srihari S. Naidu, editor ; foreword by Bernard Gersh and historical context by Eugene Braunwald.
    Summary: This book provides a comprehensive clinical review of Hypertrophic Cardiomyopathy (HCM), the most common genetic disorder of the heart characterized by dysfunctional contractility at the sarcomere level, resulting in the development of abnormal and occasionally focal hypertrophy on a macroscopic level. Editor, Srihari S. Naidu, has brought together a world renowned group of experts to review various different topics but, with a practical focus that will enable readers to establish the evidence-based best practice in any potential scenario. Treatment modalities including medications, pacemakers and defibrillators, and invasive septal reduction therapy (both surgical myectomy and alcohol septal ablation) will be discussed. Chapters on genetics, family screening, lifestyle concerns, and athletic screening have additionally been added given the ongoing controversies and differences of opinion on many of these issues. Each chapter within Hypertrophic Cardiomyopathy begins with key points of knowledge and ends with clinical pearls that have not previously been disseminated to the wider community. The practical approach of the entire book continues with dedicated chapters on creating a Center of Excellence, including how to facilitate the multi-disciplinary approach, and on case-based reviews and discussions allowing readers to further understand how to integrate the knowledge gained from each chapter into the comprehensive and longitudinal care of the individual patient and family. The last chapter takes the reader through the management of actual patients, showing over decades the nuances to diagnosis and management and the sometimes abrupt changes in the course of their diseases that necessitate correspondingly abrupt modifications in treatment. This book will be an essential text for Trainees, Fellows, Residents and board-certified physicians in cardiology, interventional cardiology, cardiac surgery, cardiac imaging, sports medicine, paediatric cardiology, genetics and genetic counselling, and electrophysiology.

    Contents:
    Introduction
    Foreword
    Hypertrophic Cardiomyopathy: The Past, The Present, and The Future
    Natural History of Untreated Hypertrophic Cardiomyopathy
    Pathology & Pathophysiology
    Approach to Diagnosis: Echocardiography
    Cardiac MRI in Diagnosis and Management
    Genetics of HCM and Role of Genetic Testing
    Assessment of Heart Failure: Invasive and Non-invasive Methods
    Assessment of Syncope
    Pediatric Diagnosis and Management
    Sudden Cardiac Death Risk Assessment
    Youth and Athletic Screening: Rationale, Methods and Outcome
    Lifestyle Modification: Diet, Exercise, Sports and Other Issues
    Family Screening: Who, When and How
    Medical Therapy: From Beta?Blockers to Disopyramide
    Indications and Outcome of PPM and ICD Placement
    Management of Arrhythmia: Medications, Electrophysiology Studies and Ablation
    Indications for and Individualization of Septal Reduction Therapy
    Surgical Myectomy and Associated Procedures: Techniques and Outcomes
    Alcohol Septal Ablation: Technique and Outcome
    End-Stage Diastolic and Systolic Heart Failure: Evaluation and Timing of Heart Transplantation
    Approach to the Initial and Follow-Up Visits
    Evaluation and Management of Hypertrophic Cardiomyopathy Patients through Noncardiac Surgery and Pregnancy
    Constructing a Hypertrophic Cardiomyopathy Center of Excellence
    Longitudinal Case-Based Presentations in HCM.
    Digital Access Springer 2015
  • Article
    Todd TR, Weinman G, McIntyre D, Simon JB, Groll A, West RO.
    Can J Surg. 1979 May;22(3):283-5.
    A 25-year-old white woman who had previously undergone two operations for peptic ulcer disease, and was addicted to drugs and alcohol, had massive hemorrhage from the small intestine. Angiography pinpointed the jejunum as the source of bleeding. Because the patient had a coagulopathy she was considered a poor risk for surgery. Bleeding was controlled by embolization with sterile, commercially available Gelfoam (Upjohn) which was injected into the offending branch of the superior mesenteric artery. This is believed to be only the third documented case of embolization of small intestinal vessels. A review of the available literature is presented and the value of Gelfoam embolization as an adjunct in the control of hemorrhage in selected patients is stressed.
    Digital Access Access Options